[Clinical evaluation of prostate antigen (PA) in prostate cancer]
[Article in
Japanese]
- PMID: 2411962
Item in Clipboard
[Clinical evaluation of prostate antigen (PA) in prostate cancer]
[Article in
Japanese]
Gan No Rinsho.
1985 May.
Abstract
Prostate antigen (PA) which was isolated at 1979 and may have a probability to be a tumor marker of prostate cancer has been evaluated clinically using an EIA for detection method. From mean +3 S.D. of normal male subjects, upper cut-off values of Americans and Japanese have been decided as 2.5 and 1.2 ng/ml, respectively. Of a total of 1,109 assayed serum PA, positive rate in prostate cancer were 78% in Americans (n = 570) and 61% in Japanese (n = 45), whereas false positive rate was lower in Japanese. Serum PA values could be used for speculation of patients' prognosis and monitoring in prostate cancer.
Similar articles
-
[Tumor markers of prostate cancer--evaluation of serum PAP and PA].Gan No Rinsho. 1985 May;31(6 Suppl):664-9. Gan No Rinsho. 1985. PMID: 2411965 Japanese.
-
[Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].Hinyokika Kiyo. 1987 Jun;33(6):883-8. Hinyokika Kiyo. 1987. PMID: 2445188 Japanese.
-
[Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].Hinyokika Kiyo. 1988 Aug;34(8):1389-96. Hinyokika Kiyo. 1988. PMID: 2461644 Japanese.
-
Prostate-specific antigen in prostate cancer.Int J Biol Markers. 1986 May-Aug;1(2):67-76. Int J Biol Markers. 1986. PMID: 2448397 Review.
-
Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.Scand J Urol Nephrol Suppl. 1994;162:73-87; discussion 115-27. Scand J Urol Nephrol Suppl. 1994. PMID: 7529430 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical